Police have arrested another doctor and three clinical staff after patients were allegedly given medical exemption certificates for Covid jabs without having a consultation. The force also warned there would be no let up in its efforts to stamp out such abuses. It comes after a doctor in Yuen Long was arrested earlier this month for selling over 6,000 of the certificates since August. Vanessa Cheng reports:

Covid case numbers are up slightly at 5,687 after falling for four consecutive days. But officials say the number of patients being treated in public hospitals has fallen to around 2,400. Aaron Tam reports:

Government pandemic adviser, Lau Yu-lung, says the baby version of the BioNTech coronavirus jab could be available in Hong Kong as early as next month. The lower dosage, if approved, is meant for children from six months to five years old. This comes after the government said it had received an application from the vaccine manufacturer, Pfizer, to supply the mini shots in Hong Kong. Professor Lau, who is also the chair of paediatrics at the University of Hong Kong, told Damon Pang it should not take long for the authorities to finish vetting the jabs:

A police clinical psychologist is urging people to be vigilant against telephone scams, saying the practise is prevalent in Hong Kong and the con artists are "highly trained professionals". Woo Chin-pang was commenting after police said they recorded more than 900 phone scams in the first seven months of this year - up 60 percent compared to the same period last year. Cases where fraudsters impersonated health officials were on the rise. Woo told Samantha Butler that the scammers were trained in psychological concepts and techniques used by marketers and salespeople:

Tencent Music Entertainment Group has closed at $18.22 after debuting on the Hong Kong stock exchange on Wednesday. That was slightly above its US-listed primary stock which closed at the equivalent of $17.98. The online music firm opened flat at $18 on Wednesday morning. It announced last week that it would carry out a listing by introduction in Hong Kong, without issuing any new shares or raising fresh capital. It is a faster route to list here than normal IPOs. The debut comes as US audit officials begin reviewing US-listed Chinese firms here, after mainland authorities agreed to allow them to do so to avert the companies' potential delisting. Dickie Wong, executive director of research for Kingston Securities, spoke to Joanne Wong: